Physician profile
Brien P Daly
NPI 1174519599
$647.18
in general payments reported to CMS, 2019-2025
12 companies · $29.69 in 2025
The $29.69 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $279 · 2021: $127 · 2023: $150 · 2024: $62.20 · 2025: $29.69.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $241.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $241.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Roche Diagnostics Corporation | $129.59 | 2019 | |
| Coopersurgical, INC. | $104.38 | 2019-2023 | Paragard T 380a |
| Baxter Healthcare | $84.65 | 2021 | |
| Hologic Sales and Service, LLC | $73.00 | 2019-2024 | Myosure Tissue Removal Device, Acessa Provu System |
| Sumitomo Pharma America, INC. | $57.62 | 2023 | Myfembree |
| Abbvie INC. | $46.71 | 2019-2023 | Lo Loestrin Fe |
| Medicem INC. | $45.22 | 2021-2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $29.69 | 2025 | |
| Ethicon US, LLC | $24.06 | 2021 | |
| Covidien LP | $23.40 | 2019 | |
| Therapeuticsmd, INC. | $16.44 | 2019 | |
| Millicent US INC | $12.42 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brien Daly listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.